Differential Changes in Inflammatory Mononuclear Phagocyte and T-Cell Profiles within Psoriatic Skin during Treatment with Guselkumab vs. Secukinumab-Reference-Cited by-同舟云学术

Differential Changes in Inflammatory Mononuclear Phagocyte and T-Cell Profiles within Psoriatic Skin during Treatment with Guselkumab vs. Secukinumab

Published:2021-07 Issue:7 Volume:141 Page:1707-1718.e9
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Mehta Heena^ORCID,Mashiko Shunya^ORCID,Angsana Julianty^ORCID,Rubio Manuel^ORCID,Hsieh Ya-Ching M.^ORCID,Maari Catherine^ORCID,Reich Kristian^ORCID,Blauvelt Andrew^ORCID,Bissonnette Robert^ORCID,Muñoz-Elías Ernesto J.^ORCID,Sarfati Marika^ORCID

Funder

Janssen Research and Development

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference62 articles.

1. The interplay between keratinocytes and immune cells in the pathogenesis of psoriasis;Albanesi;Front Immunol,2018

2. Regulatory T cells in skin;Ali;Immunology,2017

3. Toxic epidermal necrolysis induced by vemurafenib after nivolumab failure;Arenbergerova;J Eur Acad Dermatol Venereol,2017

4. Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial

5. Transcriptional and functional analysis of CD1c+ human dendritic cells identifies a CD163+ subset priming CD8+CD103+ T cells;Bourdely;Immunity,2020

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The immunologic role of IL-23 in psoriatic arthritis: a potential therapeutic target;Expert Opinion on Biological Therapy;2024-09-08

2. Differential Pharmacodynamic Effects on Psoriatic Biomarkers by Guselkumab Versus Secukinumab Correlate with Long-Term Efficacy: An ECLIPSE Substudy;JID Innovations;2024-09

3. Guselkumab Reduces Disease- and Mechanism-Related Biomarkers More Than Adalimumab in Patients with Psoriasis: A VOYAGE 1 Substudy;JID Innovations;2024-09

4. The role and therapeutic strategies for tissue‐resident memory T cells, central memory T cells, and effector memory T cells in psoriasis;Immunology;2024-08-13

5. Research trends and hotspots in biologics for plaque psoriasis: A bibliometric study from 2004 to 2023;Heliyon;2024-08